发明名称 HETEROCYCLIC COMPOUNDS AND USES THEREOF
摘要 Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
申请公布号 US2015111874(A1) 申请公布日期 2015.04.23
申请号 US201414506429 申请日期 2014.10.03
申请人 INFINITY PHARMACEUTICALS, INC. 发明人 Castro Alfredo C.;Evans Catherine A.;JANARDANANNAIR Somarajannair;LESCARBEAU Andre;LIU Tao;TREMBLAY Martin R.
分类号 C07D487/04;C07D403/12;C07D471/08;C07D401/14;C07D471/04 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound of Formula (I″) or Formula (A″): wherein: R1 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, —COR2, —COOR3, or —CONR4R5; z is 0, 1, 2, or 3; each instance of R3a is independently hydrogen, alkyl, alkenyl, alkynyl, alkoxyl, halogen, cyano, amino, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; B is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, —COR2, —COOR3, —CONR4R5, or —Si(R6)3; wherein R2, R3, R4, R5, and R6 are each, independently, hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl; R1c is hydrogen, alkyl, alkenyl, or alkynyl; R2c is hydrogen, alkyl, alkenyl, or alkynyl; Wd is heteroaryl, cycloalkyl, heterocycloalkyl, or aryl; and X is CR1a or N; wherein R1a is hydrogen, halo, alkyl, alkenyl, alkynyl, or CN;wherein each alkyl, alkenyl, or alkynyl is optionally substituted with one or more halo, OH, alkoxy, NH2, NH(alkyl), N(alkyl)2, COH, CO(alkyl), COOH, COO(alkyl), CONH2, CONH(alkyl), CON(alkyl)2, S(O)(alkyl), S(O)2(alkyl), cycloalkyl, heterocycloalkyl, aryl or heteroaryl;wherein each cycloalkyl, heterocycloalkyl, aryl or heteroaryl is optionally substituted with one or more halo, alkyl, alkenyl, alkynyl, OH, alkoxy, oxo, NH2, NH(alkyl), N(alkyl)2, COH, CO(alkyl), COOH, COO(alkyl), CONH2, CONH(alkyl), CON(alkyl)2, S(O)(alkyl), or S(O)2(alkyl);wherein in Formula (I″), when X is CH, B is unsubstituted phenyl, and Wd is  then R1 is not hydrogen, CH2Si(CH3)3, methyl, (CH2)NH2, (CH2)2NH2, (CH2)NHSO2CH3, or (CH2)—NHC(O)R1x; n is 1 or 2; R1x is methyl, C2 alkenyl, cyclohexyl, cyclopentyl, tetrahydrofuranyl, furanyl, or pyrrolidinyl, where the alkenyl, cyclohexyl, cyclopentyl, tetrahydrofuranyl, furanyl, or pyrrolidinyl is optionally substituted with one or two groups independently selected from oxo and cyano;wherein in Formula (A″), when X is CH, B is unsubstituted phenyl, and Wd is  then R1 is not phenyl; or a pharmaceutically acceptable form thereof.
地址 Cambridge MA US